πŸ‡ΊπŸ‡Έ FDA
Patent

US 9095621

Oligome-bis-chromonyl compound conjugates

granted A61KA61K31/353A61K47/60

Quick answer

US patent 9095621 (Oligome-bis-chromonyl compound conjugates) held by Nektar Therapeutics expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/353, A61K47/60, A61P, A61P11/06